实施次要重症肺炎标准实时电子临床决策支持后的ICU利用情况
该研究为阶梯楔形、集群对照的临床决策支持实施试验的计划性二次分析,纳入美国犹他州和爱达荷州Intermountain Health 6个地理集群的16家医院中,从急诊入院、入院时不需要血管升压药或无创正压通气的成人肺炎患者,共2747例(实施前1814例,实施后933例)。实施后患者暴露于基于客观严重程度评分(次要重症社区获得性肺炎标准)的自动、开环、综合性临床决策支持,辅助病房与ICU的收治决策。混合效应回归模型显示,实施后30天无ICU天数增加1.04天(95%CI 0.48-1.59;p<0.001);转入病房、72小时内转入ICU和接受危重症治疗的比值降低57%(OR 0.43;95%CI 0.26-0.68;p<0.001);入院72小时内死亡率无变化(OR 1.08;95%CI 0.56-2.01;p=0.82),而30天全因死亡率降低(OR 0.71;95%CI 0.52-0.96;p=0.03)。作者认为,使用次要重症社区获得性肺炎标准的电子临床决策支持指导急诊肺炎患者收治决策,与ICU利用率的安全降低相关。
要点
- 在16家医院、2747例急诊肺炎且入院时无需血管升压药或无创正压通气的成人中,实施嵌入次要重症社区获得性肺炎标准的自动临床决策支持后,30天无ICU天数增加1.04天(95%CI 0.48-1.59;p<0.001)。
- 实施后,转入病房、72小时内转入ICU和接受危重症治疗的比值降低57%(OR 0.43;95%CI 0.26-0.68;p<0.001)。
- 实施后,入院72小时内死亡率无变化(OR 1.08;95%CI 0.56-2.01;p=0.82),30天全因死亡率降低(OR 0.71;95%CI 0.52-0.96;p=0.03)。
- 该决策支持为自动、开环、综合性工具,基于客观严重程度评分(次要重症社区获得性肺炎标准)辅助病房与ICU收治决策。
- 研究为阶梯楔形、集群对照实施试验的计划性二次分析,实施前1814例、实施后933例,中位年龄71岁,中位Elixhauser指数17,48%为女性,95%为白人。
适用人群与场景
- 成人(中位年龄71岁)从急诊收入院、出院国际疾病分类第10版编码为肺炎或脓毒症/呼吸衰竭、且急诊胸部影像学符合肺炎的患者。
- 入院时不需要血管升压药或无创正压通气的患者。
- 研究场所为美国犹他州和爱达荷州Intermountain Health的16家医院、6个地理集群。
诊断标准与关键阈值
- 使用次要重症社区获得性肺炎标准作为客观严重程度评分,嵌入自动临床决策支持以辅助病房与ICU收治决策。
处置流程与药物剂量
- 实施后,患者暴露于自动、开环、综合性临床决策支持,该工具基于客观严重程度评分(次要重症社区获得性肺炎标准)辅助病房与ICU的收治决策。
研究设计与关键结果
- 研究设计为阶梯楔形、集群对照的临床决策支持实施试验的计划性二次分析,纳入2747例患者(实施前1814例,实施后933例),中位年龄71岁,中位Elixhauser指数17,48%为女性,95%为白人。
- 主要终点:混合效应回归模型(集群为随机效应)估计,实施基于次要重症社区获得性肺炎标准的临床决策支持使30天无ICU天数增加1.04天(95%CI 0.48-1.59;p<0.001)。
- 次要终点:实施后转入病房、72小时内转入ICU和接受危重症治疗的比值降低57%(OR 0.43;95%CI 0.26-0.68;p<0.001)。
- 次要终点:入院72小时内死亡率无变化(OR 1.08;95%CI 0.56-2.01;p=0.82)。
- 次要终点:30天全因死亡率降低(OR 0.71;95%CI 0.52-0.96;p=0.03)。
证据类型、等级与局限
- 证据类型:阶梯楔形、集群对照的临床决策支持实施试验的计划性二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,使用次要重症社区获得性肺炎标准的电子临床决策支持指导急诊肺炎患者收治决策,与ICU利用率的安全降低相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine if the implementation of automated clinical decision support (CDS) with embedded minor severe community-acquired pneumonia (sCAP) criteria was associated with improved ICU utilization among emergency department (ED) patients with pneumonia who did not require vasopressors or positive pressure ventilation at admission.
DESIGN: Planned secondary analysis of a stepped-wedge, cluster-controlled CDS implementation trial.
SETTING: Sixteen hospitals in six geographic clusters from Intermountain Health; a large, integrated, nonprofit health system in Utah and Idaho.
PATIENTS: Adults admitted to the hospital from the ED with pneumonia identified by: 1) discharge International Classification of Diseases , 10th Revision codes for pneumonia or sepsis/respiratory failure and 2) ED chest imaging consistent with pneumonia, who did not require vasopressors or positive pressure ventilation at admission.
INTERVENTIONS: After implementation, patients were exposed to automated, open-loop, comprehensive CDS that aided disposition decision (ward vs. ICU), based on objective severity scores (sCAP).
MEASUREMENTS AND MAIN RESULTS: The analysis included 2747 patients, 1814 before and 933 after implementation. The median age was 71, median Elixhauser index was 17, 48% were female, and 95% were Caucasian. A mixed-effects regression model with cluster as the random effect estimated that implementation of CDS utilizing sCAP increased 30-day ICU-free days by 1.04 days (95% CI, 0.48-1.59; p < 0.001). Among secondary outcomes, the odds of being admitted to the ward, transferring to the ICU within 72 hours, and receiving a critical therapy decreased by 57% (odds ratio [OR], 0.43; 95% CI, 0.26-0.68; p < 0.001) post-implementation; mortality within 72 hours of admission was unchanged (OR, 1.08; 95% CI, 0.56-2.01; p = 0.82) while 30-day all-cause mortality was lower post-implementation (OR, 0.71; 95% CI, 0.52-0.96; p = 0.03).
CONCLUSIONS: Implementation of electronic CDS using minor sCAP criteria to guide disposition of patients with pneumonia from the ED was associated with safe reduction in ICU utilization.
参考来源
- Carr JR, Knox DB, Butler AM, et al. ICU Utilization After Implementation of Minor Severe Pneumonia Criteria in Real-Time Electronic Clinical Decision Support. Crit Care Med. 2023. PMID: 38157205. doi:10.1097/CCM.0000000000006163
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。